PL2279206T3 - Metoda zapobiegania rozwojowi reumatoidalnego zapalenia stawów u osób z niezróżnicowanym zapaleniem stawów - Google Patents
Metoda zapobiegania rozwojowi reumatoidalnego zapalenia stawów u osób z niezróżnicowanym zapaleniem stawówInfo
- Publication number
- PL2279206T3 PL2279206T3 PL09743410T PL09743410T PL2279206T3 PL 2279206 T3 PL2279206 T3 PL 2279206T3 PL 09743410 T PL09743410 T PL 09743410T PL 09743410 T PL09743410 T PL 09743410T PL 2279206 T3 PL2279206 T3 PL 2279206T3
- Authority
- PL
- Poland
- Prior art keywords
- arthritis
- subjects
- development
- preventing
- undifferentiated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2827—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70521—CD28, CD152
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5033608P | 2008-05-05 | 2008-05-05 | |
US12/387,359 US7915222B2 (en) | 2008-05-05 | 2009-05-01 | Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis |
EP20090743410 EP2279206B1 (en) | 2008-05-05 | 2009-05-05 | Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis |
PCT/US2009/042761 WO2009137424A1 (en) | 2008-05-05 | 2009-05-05 | Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2279206T3 true PL2279206T3 (pl) | 2015-09-30 |
Family
ID=41264941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL09743410T PL2279206T3 (pl) | 2008-05-05 | 2009-05-05 | Metoda zapobiegania rozwojowi reumatoidalnego zapalenia stawów u osób z niezróżnicowanym zapaleniem stawów |
Country Status (25)
Country | Link |
---|---|
US (3) | US7915222B2 (pl) |
EP (2) | EP2891665A1 (pl) |
JP (1) | JP2011522795A (pl) |
KR (1) | KR20110014180A (pl) |
CN (1) | CN102037010A (pl) |
AR (1) | AR071672A1 (pl) |
AU (1) | AU2009244448B2 (pl) |
BR (1) | BRPI0912249A2 (pl) |
CA (1) | CA2723698C (pl) |
CL (1) | CL2009001082A1 (pl) |
DK (1) | DK2279206T3 (pl) |
EA (1) | EA201001749A1 (pl) |
ES (1) | ES2539840T3 (pl) |
HK (2) | HK1148291A1 (pl) |
HR (1) | HRP20150552T1 (pl) |
HU (1) | HUE025256T2 (pl) |
IL (1) | IL208691A (pl) |
MX (1) | MX2010011503A (pl) |
NZ (1) | NZ589020A (pl) |
PL (1) | PL2279206T3 (pl) |
PT (1) | PT2279206E (pl) |
SI (1) | SI2279206T1 (pl) |
TW (2) | TW201444575A (pl) |
WO (1) | WO2009137424A1 (pl) |
ZA (1) | ZA201007914B (pl) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040022787A1 (en) | 2000-07-03 | 2004-02-05 | Robert Cohen | Methods for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID |
US7915222B2 (en) * | 2008-05-05 | 2011-03-29 | Bristol-Myers Squibb Company | Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis |
JP6239517B2 (ja) * | 2011-10-10 | 2017-11-29 | メディミューン リミテッド | 関節リウマチの治療法 |
US20140006055A1 (en) * | 2012-06-27 | 2014-01-02 | Iagnosis, Inc. | Integrated Medical Evaluation and Record Keeping System |
WO2014070840A2 (en) * | 2012-10-30 | 2014-05-08 | Emory University | Stimulating bone formation by inhibition of cd28 co-stimulation |
WO2014151230A2 (en) * | 2013-03-15 | 2014-09-25 | Bristol-Myers Squibb Company | Method of treating granulomatosis with polyangiitis |
AU2015249656A1 (en) * | 2014-04-25 | 2016-11-03 | Bristol-Myers Squibb Company | Use of CTLA4 compound for achieving drug-free remission in subjects with early RA |
KR20240046641A (ko) | 2015-04-17 | 2024-04-09 | 알파인 이뮨 사이언시즈, 인코포레이티드 | 조율가능한 친화성을 갖는 면역조절 단백질 |
MA50360A (fr) | 2017-10-10 | 2020-08-19 | Alpine Immune Sciences Inc | Protéines immunomodulatrices de variants de ctla-4 et leurs utilisations |
CN110148465B (zh) * | 2019-05-10 | 2023-07-04 | 中山大学孙逸仙纪念医院 | 一种用于分析类风湿性关节炎的系统 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5580756A (en) * | 1990-03-26 | 1996-12-03 | Bristol-Myers Squibb Co. | B7Ig fusion protein |
US7070776B1 (en) * | 1990-03-26 | 2006-07-04 | Bristol-Myers Squibb Company | Methods for blocking binding of CD28 receptor to B7 |
US5851795A (en) * | 1991-06-27 | 1998-12-22 | Bristol-Myers Squibb Company | Soluble CTLA4 molecules and uses thereof |
US5770197A (en) * | 1991-06-27 | 1998-06-23 | Bristol-Myers Squibb Company | Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules |
US6090914A (en) * | 1991-06-27 | 2000-07-18 | Bristol-Myers Squibb Company | CTLA4/CD28Ig hybrid fusion proteins and uses thereof |
DE122007000078I2 (de) * | 1991-06-27 | 2011-01-13 | Bristol Myers Squibb Co | CTL4A-Rezeptor, ihn enthaltenden Fusionsproteine und deren Verwendung |
US5844095A (en) * | 1991-06-27 | 1998-12-01 | Bristol-Myers Squibb Company | CTLA4 Ig fusion proteins |
CA2154487A1 (en) * | 1993-01-21 | 1994-08-04 | Nicholas S. Hill | Vaccines and methods for preventing and treating fescue toxicosis in herbivores |
US5773253A (en) * | 1993-01-22 | 1998-06-30 | Bristol-Myers Squibb Company | MYPPPY variants of CTL A4 and uses thereof |
US6750334B1 (en) * | 1996-02-02 | 2004-06-15 | Repligen Corporation | CTLA4-immunoglobulin fusion proteins having modified effector functions and uses therefor |
EP0892643B2 (en) * | 1996-03-20 | 2009-09-02 | Bristol-Myers Squibb Company | Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
US20030219863A1 (en) * | 1997-01-31 | 2003-11-27 | Bristol-Myers Squibb Company | Soluble CTLA4 mutant molecules and uses thereof |
ZA98533B (en) * | 1997-01-31 | 1999-07-22 | Bristol Myers Squibb Co | Soluble CTLA4 mutant molecules and uses thereof. |
US7094874B2 (en) * | 2000-05-26 | 2006-08-22 | Bristol-Myers Squibb Co. | Soluble CTLA4 mutant molecules |
KR20030007899A (ko) * | 2000-06-09 | 2003-01-23 | 브리스톨-마이어스스퀴브컴파니 | 림프구성 신호의 차단 및 lfa-1 매개 접착의 차단을통한 세포-매개 면역 반응의 조절 방법 |
US20040022787A1 (en) * | 2000-07-03 | 2004-02-05 | Robert Cohen | Methods for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID |
TWI322153B (en) * | 2000-07-03 | 2010-03-21 | Bristol Myers Squibb Co | Methods for treating rheumatic diseases using a soluble ctla4 molecule |
AU2002243905B2 (en) * | 2001-01-26 | 2007-11-08 | Emory University | Methods of inducing organ transplant tolerance and correcting hemoglobinopathies |
PL204899B1 (pl) * | 2001-05-23 | 2010-02-26 | Bristol Myers Squibb Co | Zastosowanie rozpuszczalnej zmutowanej cząsteczki CTLA4 |
WO2004058800A2 (en) * | 2002-12-23 | 2004-07-15 | Bristol-Myers Squibb Company | Mammalian cell culture processes for protein production |
ES2354610T5 (es) * | 2002-12-23 | 2020-09-14 | Bristol Myers Squibb Co | Mejora de la calidad del producto en procedimientos de cultivo de células de mamífero para la producción de proteína |
BRPI0413326A (pt) * | 2003-08-04 | 2006-10-10 | Bristol Myers Squibb Co | métodos para tratar doença cardiovasculares empregando-se uma molécula ctla4 solúvel |
JP5058991B2 (ja) | 2005-06-29 | 2012-10-24 | コンプメディクス リミテッド | 導電ブリッジを備えるセンサ・アセンブリ |
WO2007024964A1 (en) * | 2005-08-22 | 2007-03-01 | Incept, Llc | Flared stents and apparatus and methods for making and using them |
PL2253644T3 (pl) | 2005-12-20 | 2014-04-30 | Bristol Myers Squibb Co | Kompozycje i sposoby wytwarzania kompozycji |
CN101822820A (zh) | 2005-12-20 | 2010-09-08 | 布里斯托尔—迈尔斯斯奎布公司 | 稳定蛋白质制剂 |
US7528111B2 (en) * | 2006-05-12 | 2009-05-05 | Bristol-Myers Squibb Company | Method of vaccinating subjects receiving immune modulating therapy |
US7915222B2 (en) * | 2008-05-05 | 2011-03-29 | Bristol-Myers Squibb Company | Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis |
-
2009
- 2009-05-01 US US12/387,359 patent/US7915222B2/en active Active
- 2009-05-05 ES ES09743410.4T patent/ES2539840T3/es active Active
- 2009-05-05 AR ARP090101621A patent/AR071672A1/es unknown
- 2009-05-05 BR BRPI0912249A patent/BRPI0912249A2/pt not_active Application Discontinuation
- 2009-05-05 EP EP15152246.3A patent/EP2891665A1/en not_active Withdrawn
- 2009-05-05 WO PCT/US2009/042761 patent/WO2009137424A1/en active Application Filing
- 2009-05-05 CA CA2723698A patent/CA2723698C/en active Active
- 2009-05-05 TW TW103129409A patent/TW201444575A/zh unknown
- 2009-05-05 HU HUE09743410A patent/HUE025256T2/en unknown
- 2009-05-05 PT PT97434104T patent/PT2279206E/pt unknown
- 2009-05-05 DK DK09743410.4T patent/DK2279206T3/en active
- 2009-05-05 CL CL2009001082A patent/CL2009001082A1/es unknown
- 2009-05-05 AU AU2009244448A patent/AU2009244448B2/en not_active Ceased
- 2009-05-05 MX MX2010011503A patent/MX2010011503A/es active IP Right Grant
- 2009-05-05 EP EP20090743410 patent/EP2279206B1/en active Active
- 2009-05-05 JP JP2011508582A patent/JP2011522795A/ja active Pending
- 2009-05-05 NZ NZ589020A patent/NZ589020A/en not_active IP Right Cessation
- 2009-05-05 TW TW098114831A patent/TWI454278B/zh not_active IP Right Cessation
- 2009-05-05 KR KR1020107027221A patent/KR20110014180A/ko not_active Application Discontinuation
- 2009-05-05 PL PL09743410T patent/PL2279206T3/pl unknown
- 2009-05-05 SI SI200931228T patent/SI2279206T1/sl unknown
- 2009-05-05 CN CN2009801162049A patent/CN102037010A/zh active Pending
- 2009-05-05 EA EA201001749A patent/EA201001749A1/ru unknown
-
2010
- 2010-10-13 IL IL208691A patent/IL208691A/en not_active IP Right Cessation
- 2010-11-04 ZA ZA2010/07914A patent/ZA201007914B/en unknown
-
2011
- 2011-02-10 US US13/024,601 patent/US8435952B2/en active Active
- 2011-03-07 HK HK11102241.0A patent/HK1148291A1/xx unknown
- 2011-03-07 HK HK15108768.6A patent/HK1208230A1/xx unknown
-
2013
- 2013-03-27 US US13/851,166 patent/US9012408B2/en active Active
-
2015
- 2015-05-25 HR HRP20150552TT patent/HRP20150552T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1208230A1 (en) | Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis | |
IL244197A0 (en) | Antibodies against cd100 and methods of using them | |
EP2508487A4 (en) | WASTEWATER PRETREATMENT METHOD AND EFFLUENT TREATMENT METHOD USING THE PRETREATMENT PROCESS | |
EP2414535A4 (en) | BIOMARKERS RELATED TO INSULIN RESISTANCE AND METHODS OF USE | |
EP2315220A4 (en) | REACTOR COMPONENT AND REACTOR | |
EP2189519A4 (en) | CELL CULTURE INSTRUMENT AND CELL CUKLTURE PROCESS WITH THIS | |
EP2335060A4 (en) | ELECTROCHEMICAL BIOSENSOR STRUCTURE AND METHOD OF MEASUREMENT THEREWITH | |
EP2164981A4 (en) | METHODS AND DEVICES FOR DETERMINING ANALYTES | |
EP2280442A4 (en) | FUEL CELL AND METHOD OF DISASSEMBLY | |
PT2209805T (pt) | Um antigénio associado a artrite reumatoide | |
EP2411861A4 (en) | CONTACT LENS WITH SOUTHERN SAGITTAL VARIATION AND METHODS OF MAKING AND USING SAME | |
HRP20190371T1 (hr) | Solarna ćelija i postupak njezine proizvodnje | |
EP2262039A4 (en) | Cell selector and cell with it | |
HK1212698A1 (zh) | 噻唑基和噁唑基異喹哪啶以及它們的使用方法 | |
EP2343759A4 (en) | BATTERY COMPONENT AND BATTERY | |
EP2314678A4 (en) | MICRO-RNA ASSOCIATED WITH RHEUMATOID ARTHRITIS | |
AP2011005536A0 (en) | Treatment of rheumatoid arthritis with mammal betadefensins. | |
EP2414962A4 (en) | METHOD, SYSTEM AND MEANS FOR THE ASSOCIATION OF PEOPLE WITH RHEUMATOID ARTHRITIS WITH HEART CIRCULATION DISEASE | |
EP2483621A4 (en) | WASTE TREATMENT TANK WITH TWO DOORS AND ENVIRONMENTAL SEPARATION BETWEEN DOORS | |
TWI372256B (en) | Test apparature and test method | |
TWI373159B (en) | Electrolyte for electrochemical device and the electrochemical device thereof | |
GB0822140D0 (en) | Methods and reagents | |
EP2185685A4 (en) | NEW PROCESSES AND NEW CELL LINES | |
EP2199802A4 (en) | CONTAINER AND ANALYSIS CONTAINER USING THE SAME | |
TH102028B (th) | กระป๋องแบตเตอรี่ วิธีสำหรับการผลิตสิ่งเดียวกันนั้น และแบตเตอรี่ |